Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations

Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amelia J. Averitt, Chunhua Weng, Patrick Ryan, Adler Perotte
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f2941ae407db4ad197e6d29fe2663bf3
record_format dspace
spelling oai:doaj.org-article:f2941ae407db4ad197e6d29fe2663bf32021-12-02T15:36:31ZTranslating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations10.1038/s41746-020-0277-82398-6352https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf32020-05-01T00:00:00Zhttps://doi.org/10.1038/s41746-020-0277-8https://doaj.org/toc/2398-6352Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises concerns for generalizability. We compared reported data from RCTs with real-world data from the electronic health records of a large, academic medical center that was curated according to RCT eligibility criteria. Our results show fundamental differences between the RCT population and our observational cohorts, which suggests that eligibility criteria may be insufficient for identifying the applicable real-world population in which RCT evidence will replicate.Amelia J. AverittChunhua WengPatrick RyanAdler PerotteNature PortfolioarticleComputer applications to medicine. Medical informaticsR858-859.7ENnpj Digital Medicine, Vol 3, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Computer applications to medicine. Medical informatics
R858-859.7
spellingShingle Computer applications to medicine. Medical informatics
R858-859.7
Amelia J. Averitt
Chunhua Weng
Patrick Ryan
Adler Perotte
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
description Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises concerns for generalizability. We compared reported data from RCTs with real-world data from the electronic health records of a large, academic medical center that was curated according to RCT eligibility criteria. Our results show fundamental differences between the RCT population and our observational cohorts, which suggests that eligibility criteria may be insufficient for identifying the applicable real-world population in which RCT evidence will replicate.
format article
author Amelia J. Averitt
Chunhua Weng
Patrick Ryan
Adler Perotte
author_facet Amelia J. Averitt
Chunhua Weng
Patrick Ryan
Adler Perotte
author_sort Amelia J. Averitt
title Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
title_short Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
title_full Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
title_fullStr Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
title_full_unstemmed Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
title_sort translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/f2941ae407db4ad197e6d29fe2663bf3
work_keys_str_mv AT ameliajaveritt translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations
AT chunhuaweng translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations
AT patrickryan translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations
AT adlerperotte translatingevidenceintopracticeeligibilitycriteriafailtoeliminateclinicallysignificantdifferencesbetweenrealworldandstudypopulations
_version_ 1718386327437705216